Nortech Systems Incorporated (NSYS) AI Stock Analysis

Nortech Systems Incorporated specializes in providing comprehensive design and manufacturing solutions for electromedical devices, electromechanical systems, assemblies, and components across the United States, Mexico, and China. The company delivers project management, design, testing, prototyping, manufacturing, supply chain management, and post-market support services. Its capabilities include medical devices, printed circuit board assemblies (PCBAs), wire and cable assemblies, and complex electromechanical assemblies. These offerings serve original equipment manufacturers in aerospace and defense, medical technology, and industrial sectors, alongside ongoing engineering and repair services.

Revenue grew from $115.2M in FY2021 to a peak of $139.3M in FY2023, before falling 8.0% to $128.1M in FY2024 and declining 7.6% to $118.4M in FY2025. Between FY2020 and FY2025, revenue achieved a 5-year CAGR of 2.6%. Profitability fluctuated, moving from a net income of $7.2M in FY2021 to net losses of -$1.3M in FY2024 and -$252,000 in FY2025. Over the trailing twelve months, revenue reached $124.7M with an operating margin of 1.9% and net margin of 0.8%. In the latest quarter ended June 30, 2026, quarterly revenue grew 9.3% year-over-year, while quarterly earnings fell 2.5%.

As of June 30, 2026, Nortech Systems held $1.4M in cash and short-term investments and $17.9M in total debt, resulting in net debt of $16.5M. Total assets stood at $80.0M compared to shareholders' equity of $35.5M, yielding a debt-to-equity ratio of 0.50 and a current ratio of 1.78. In FY2025, the company generated $2.7M in operating cash flow and $2.1M in free cash flow, while capital expenditures totaled $661,000. Over five years, the company's share count increased by 4.1%.

Nortech Systems has a market cap of $29.5M and an enterprise value of $49.1M. The stock trades at a trailing P/E of 28.7x, above the 24.6x median of its US-listed Healthcare peers. Its enterprise value-to-EBITDA stands at 13.1x compared to the peer median of 12.0x, while its price-to-sales of 0.2x is below the peer median of 4.1x. Over the past year, NSYS shares gained 9.7%, trailing the S&P 500 return of 16.8%. Over five years, the stock dropped 8.6%, compared to an 83.0% gain for the benchmark index.

Nortech Systems does not have published analyst consensus ratings, price targets, or earnings estimates in the tracked coverage. The company's last closing share price was $10.32 as of October 16, 2026. The next scheduled earnings report date for the company is November 12, 2026.

This page is an AI-written research summary of Nortech Systems Incorporated (NSYS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: NSYS income statement, NSYS balance sheet, NSYS key metrics, NSYS chart. See the NSYS stock overview for the latest quote and news.